ScholarIQanswers from OpenAlex
Universitair Ziekenhuis Leuven
InstitutionResearch output, impact & collaborations
Universitair Ziekenhuis Leuven is a institution indexed in ScholarIQ from OpenAlex.
What is known about Universitair Ziekenhuis Leuven?
ScholarIQrecord summary
Universitair Ziekenhuis Leuven is a research organisation in Leuven, BE. OpenAlex records 18,212 works and 1,597,361 citations for it. 2,572 researchers list it as their most recent affiliation.
How many works does Universitair Ziekenhuis Leuven have?
ScholarIQindexed works
Universitair Ziekenhuis Leuven has 18,212 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Universitair Ziekenhuis Leuven have?
ScholarIQcitation count
Universitair Ziekenhuis Leuven has 1,597,361 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Universitair Ziekenhuis Leuven?
ScholarIQresearcher count
Universitair Ziekenhuis Leuven has 2,572 researchers in the ScholarIQ index.
What is the average h-index at Universitair Ziekenhuis Leuven?
ScholarIQavg h-index
Universitair Ziekenhuis Leuven has an average h-index of 80.4 in OpenAlex.
What is the ROR of Universitair Ziekenhuis Leuven?
ScholarIQror
The ROR for Universitair Ziekenhuis Leuven is on the source record.
What is the OpenAlex record for Universitair Ziekenhuis Leuven?
ScholarIQopenalex
The OpenAlex for Universitair Ziekenhuis Leuven is on the source record.
What is the Wikidata of Universitair Ziekenhuis Leuven?
ScholarIQwikidata
The Wikidata for Universitair Ziekenhuis Leuven is on the source record.
Who are the most-cited researchers behind Universitair Ziekenhuis Leuven?
ScholarIQtop researchers by citations
What are the most-cited papers on Universitair Ziekenhuis Leuven?
ScholarIQmost cited works
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Kevin C. Oeffinger, Ann Mertens, Charles A. Sklar, Toana Kawashima, Melissa M. Hudson, Anna T. Meadows, Debra L. Friedman, Neyssa Marina, Wendy L. Hobbie, Nina S. Kadan‐Lottick, Cindy L. Schwartz, Wendy M. Leisenring, Leslie L. Robison
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg, Jack Satsangi, Tariq Ahmad, Ian Arnott, Çharles N. Bernstein, Steven R. Brant, R. Caprilli, Jean–Frédéric Colombel, Christoph Gasché, Karel Geboes, Derek P. Jewell, Amir Karban, Edward V. Loftus, A. S. Peña, Robert H. Riddell, David B. Sachar, Stefan Schreiber, A. Hillary Steinhart, Stephan R. Targan, Séverine Vermeire, Bryan F. Warren
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
James C. Yao, Manisha H. Shah, Tetsuhide Ito, C. Lombard Bohas, Edward M. Wolin, Eric Van Cutsem, Timothy J. Hobday, Takuji Okusaka, Jaume Capdevila, Elisabeth G.E. de Vries, Paola Tomassetti, Marianne Pavel, Sakina Hoosen, T Haas, Jeremie Lincy, David Lebwohl, Kjell Öberg
How much of the research on Universitair Ziekenhuis Leuven is open access?
ScholarIQopen access share
67%OPEN ACCESS